8 unknown. 8 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Unknown 8 |
| Phase 2 | 1 | Unknown 1 |
Follow Neuralgia: new trials by email Literature Review of Neuralgia trials Research Report on Neuralgia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients. iN1011-N17 HCl Suspension (Part 1), iN1011-N17 HCl Capsule (Part 1), Placebo Capsule (Part 1) - Post Herpetic Neuralgia, Pain | Phase 1 | Unknown | iN Therapeutics Co., Ltd. | 64 | 2022-11-11 | 2024-06-24 |
| Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery Onabotulinum Toxin A, Normal saline - Chronic Pain, Post-thoracotomy Pain Syndrome | Phase 1 / Phase 2 | Unknown | Allan Vestergaard Danielsen, MD | 30 | 2022-09-01 | 2021-11-09 |
| Single-dose to Evaluate the Pharmacokinetics of GTX-101 and Subcutaneous Injectable Bupivacaine in Healthy Subjects GTX-101, Bupivacaine HCl subcutaneous injection - Postherpetic Neuralgia | Phase 1 | Unknown | Grace Therapeutics Inc. | 48 | 2022-07-26 | 2023-01-23 |
| The Pharmacokinetics of GLA5PR Tablet According to the Renal Function GLA5PR tablet 75 mg, GLA5PR tablet 150 mg - Neuropathic Pain | Phase 1 | Unknown | GL Pharm Tech Corporation | 24 | 2019-09-17 | 2020-07-23 |
| PET/MRI in the Diagnosis of Chronic Pain [18F]FTC-146 - Neuropathic Pain, Nociceptive Pain | Phase 1 | Unknown | Stanford University | 190 | 2018-07-16 | 2023-07-20 |
| Pregabalin add-on for Neuropathic Pain in Cervical Myelopathy Pregabalin, Opioid - Pain, Neuropathic | Phase 1 | Unknown | Seoul National University Hospital | 60 | 2016-11-26 | 2018-08-07 |
| Safety Study Using Transcranial MR Guided Focused Ultrasound in the Treatment of Neuropathic Pain ExAblate 4000 focused ultrasound brain intervention - Functional Brain Disorders /Neuropathic Pain | Phase 1 | Unknown | University Children's Hospital, Zurich | 30 | 2008-08-01 | 2012-10-03 |
| Energy Specific Far Infrared Radiation Treatment for Sciatica Far Infrared Radiation (5μm to 20μm wavelength) - Sciatica | Phase 1 | Unknown | GAAD Medical Research Institute Inc. | 2 | 2006-01-01 | 2009-01-05 |
Chronic Pain (3) · Neuralgia, Postherpetic (2) · Pain, Postoperative (2) · Low Back Pain (1) · Movement Disorders (1) · Nociceptive Pain (1) · Osteoarthritis (1) · Pain (1) · Radiculopathy (1) · Sciatica (1) · Spinal Cord Diseases (1)
Nervous System Diseases (8) · Neurologic Manifestations (8) · Neuromuscular Diseases (8) · Pathological Conditions, Signs and Symptoms (8) · Peripheral Nervous System Diseases (8) · Signs and Symptoms (8) · Pain (7) · Central Nervous System Diseases (2) · Pathologic Processes (2) · Postoperative Complications (2) · Arthritis (1) · Back Pain (1) · Joint Diseases (1) · Mononeuropathies (1)
6-(3-fluoropropyl)-3-(2-(azepan-1-yl)ethyl)benzo(d)thiazol-2(3H)-one (1) · Analgesics, Opioid (1) · Pregabalin (1) · Saline Solution (1) · onabotulinum toxin A (1)
Allan Vestergaard Danielsen, MD (1) · GAAD Medical Research Institute Inc. (1) · GL Pharm Tech Corporation (1) · Grace Therapeutics Inc. (1) · Seoul National University Hospital (1) · Stanford University (1) · University Children's Hospital, Zurich (1) · iN Therapeutics Co., Ltd. (1)
Canada (2) · South Korea (2) · Australia (1) · Denmark (1) · Switzerland (1) · United States (1)
Allan V Danielsen, MD (1) · Anand Veeravagu, MD (1) · Chun Kee Chung, MD, PhD (1) · Eric Sicard, MD (1) · Ken Nedd, M.D. (1) · Kwasi Donyina, Ph.D. (1) · Minchang Kwon, Ph. D (1)